Eva Louwersheimer1, M Antoinette Keulen1, Martijn D Steenwijk2, Mike P Wattjes2, Lize C Jiskoot3, Hugo Vrenken2, Charlotte E Teunissen4, Bart N M van Berckel2, Wiesje M van der Flier1,5, Philip Scheltens1, John C van Swieten3,6, Yolande A L Pijnenburg1. 1. Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. 2. MS Center Amsterdam and Department of Radiology and Nuclear Medicine, Neuroscience campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. 3. Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands. 4. Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. 5. Department of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, The Netherlands. 6. Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: The logopenic variant of Primary Progressive Aphasia (lvPPA) is associated with underlying Alzheimer's disease (AD) pathology and characterized by impaired single word retrieval and repetition of phrases and sentences. OBJECTIVE: We set out to study whether logopenic aphasia is indeed the prototypic language profile in PPA patients with biomarker evidence of underlying AD pathology and to correlate language profiles with cortical atrophy patterns on MRI. METHODS: Inclusion criteria: (I) clinical diagnosis of PPA; (II) CSF profile and/or PiB-PET scan indicative for amyloid pathology; (III) availability of expert language evaluation. Based on language evaluation, patients were classified as lvPPA (fulfilling lvPPA core criteria), lvPPA extended (fulfilling core criteria plus other language disturbances), or PPA unclassifiable (not fulfilling lvPPA core criteria). Cortical atrophy patterns on MRI were visually rated and quantitative measurements of cortical thickness were performed using FreeSurfer. RESULTS: We included 22 patients (age 67±7 years, 50% female, MMSE 21±6). 41% were classified as lvPPA, 36% as lvPPA extended with additional deficits in language comprehension and/or confrontation naming, and 23% as PPA unclassifiable. By both qualitative and quantitative measurements, patients with lvPPA showed mild global cortical atrophy on MRI, whereas patients with lvPPA extended showed more focal cortical atrophy, predominantly at the left tempo-parietal side. For PPA unclassifiable, qualitative measurements revealed a heterogeneous atrophy pattern. CONCLUSION: Although most patients fulfilled the lvPPA criteria, we found that their language profiles were heterogeneous. The clinical and radiological spectrum of PPA due to underlying AD pathology is broader than pure lvPPA.
BACKGROUND: The logopenic variant of Primary Progressive Aphasia (lvPPA) is associated with underlying Alzheimer's disease (AD) pathology and characterized by impaired single word retrieval and repetition of phrases and sentences. OBJECTIVE: We set out to study whether logopenic aphasia is indeed the prototypic language profile in PPApatients with biomarker evidence of underlying AD pathology and to correlate language profiles with cortical atrophy patterns on MRI. METHODS: Inclusion criteria: (I) clinical diagnosis of PPA; (II) CSF profile and/or PiB-PET scan indicative for amyloid pathology; (III) availability of expert language evaluation. Based on language evaluation, patients were classified as lvPPA (fulfilling lvPPA core criteria), lvPPA extended (fulfilling core criteria plus other language disturbances), or PPA unclassifiable (not fulfilling lvPPA core criteria). Cortical atrophy patterns on MRI were visually rated and quantitative measurements of cortical thickness were performed using FreeSurfer. RESULTS: We included 22 patients (age 67±7 years, 50% female, MMSE 21±6). 41% were classified as lvPPA, 36% as lvPPA extended with additional deficits in language comprehension and/or confrontation naming, and 23% as PPA unclassifiable. By both qualitative and quantitative measurements, patients with lvPPA showed mild global cortical atrophy on MRI, whereas patients with lvPPA extended showed more focal cortical atrophy, predominantly at the left tempo-parietal side. For PPA unclassifiable, qualitative measurements revealed a heterogeneous atrophy pattern. CONCLUSION: Although most patients fulfilled the lvPPA criteria, we found that their language profiles were heterogeneous. The clinical and radiological spectrum of PPA due to underlying AD pathology is broader than pure lvPPA.
Authors: Giovanni Battistella; Valentina Borghesani; Maya Henry; Wendy Shwe; Michael Lauricella; Zachary Miller; Jessica Deleon; Bruce L Miller; Nina Dronkers; Simona M Brambati; William W Seeley; Maria Luisa Mandelli; Maria Luisa Gorno-Tempini Journal: J Neurosci Date: 2019-12-18 Impact factor: 6.167
Authors: Sladjana Lukic; Abigail E Licata; Elizabeth Weis; Rian Bogley; Buddhika Ratnasiri; Ariane E Welch; Leighton B N Hinkley; Z Miller; Adolfo M Garcia; John F Houde; Srikantan S Nagarajan; Maria Luisa Gorno-Tempini; Valentina Borghesani Journal: Front Psychol Date: 2022-06-24
Authors: David Bergeron; Maria L Gorno-Tempini; Gil D Rabinovici; Miguel A Santos-Santos; William Seeley; Bruce L Miller; Yolande Pijnenburg; M Antoinette Keulen; Colin Groot; Bart N M van Berckel; Wiesje M van der Flier; Philip Scheltens; Jonathan D Rohrer; Jason D Warren; Jonathan M Schott; Nick C Fox; Raquel Sanchez-Valle; Oriol Grau-Rivera; Ellen Gelpi; Harro Seelaar; Janne M Papma; John C van Swieten; John R Hodges; Cristian E Leyton; Olivier Piguet; Emily J Rogalski; Marsel M Mesulam; Lejla Koric; Kristensen Nora; Jeéreémie Pariente; Bradford Dickerson; Ian R Mackenzie; Ging-Yuek R Hsiung; Serge Belliard; David J Irwin; David A Wolk; Murray Grossman; Matthew Jones; Jennifer Harris; David Mann; Julie S Snowden; Patricio Chrem-Mendez; Ismael L Calandri; Alejandra A Amengual; Carole Miguet-Alfonsi; Eloi Magnin; Giuseppe Magnani; Roberto Santangelo; Vincent Deramecourt; Florence Pasquier; Niklas Mattsson; Christer Nilsson; Oskar Hansson; Julia Keith; Mario Masellis; Sandra E Black; Jordi A Matías-Guiu; María-Nieves Cabrera-Martin; Claire Paquet; Julien Dumurgier; Marc Teichmann; Marie Sarazin; Michel Bottlaender; Bruno Dubois; Christopher C Rowe; Victor L Villemagne; Rik Vandenberghe; Elias Granadillo; Edmond Teng; Mario Mendez; Philipp T Meyer; Lars Frings; Alberto Lleó; Rafael Blesa; Juan Fortea; Sang Won Seo; Janine Diehl-Schmid; Timo Grimmer; Kristian Steen Frederiksen; Pascual Sánchez-Juan; Gaël Chételat; Willemijn Jansen; Rémi W Bouchard; Robert Jr Laforce; Pieter Jelle Visser; Rik Ossenkoppele Journal: Ann Neurol Date: 2018-11 Impact factor: 10.422
Authors: Tyler E Owens; Mary M Machulda; Joseph R Duffy; Edythe A Strand; Heather M Clark; Sarah Boland; Peter R Martin; Val J Lowe; Clifford R Jack; Jennifer L Whitwell; Keith A Josephs Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Åsa Sandelius; Erik Portelius; Åsa Källén; Henrik Zetterberg; Uros Rot; Bob Olsson; Jon B Toledo; Leslie M Shaw; Virginia M Y Lee; David J Irwin; Murray Grossman; Daniel Weintraub; Alice Chen-Plotkin; David A Wolk; Leo McCluskey; Lauren Elman; Vesna Kostanjevecki; Manu Vandijck; Jennifer McBride; John Q Trojanowski; Kaj Blennow Journal: Alzheimers Dement Date: 2018-10-12 Impact factor: 21.566
Authors: Siddharth Ramanan; Daniel Roquet; Zoë-Lee Goldberg; John R Hodges; Olivier Piguet; Muireann Irish; Matthew A Lambon Ralph Journal: Brain Commun Date: 2020-10-17
Authors: Hulya Ulugut; Simone Stek; Lianne E E Wagemans; Roos J Jutten; Maria Antoinette Keulen; Femke H Bouwman; Niels D Prins; Afina W Lemstra; Welmoed Krudop; Charlotte E Teunissen; Bart N M van Berckel; Rik Ossenkoppele; Frederik Barkhof; Wiesje M van der Flier; Philip Scheltens; Yolande A L Pijnenburg Journal: J Neurol Date: 2021-07-03 Impact factor: 4.849